Antitumor effects of saffron-derived carotenoids in prostate cancer cell models

BioMed Research International

Volumn 2014, Issue , 2014, Pages

  Festuccia, Claudio ^a   Mancini, Andrea ^a   Gravina, Giovanni Luca ^a   Scarsella, Luca ^a   Llorens, Silvia ^c   Alonso, Gonzalo L ^d   Tatone, Carla ^a   Di Cesare, Ernesto ^a   Jannini, Emmanuele A ^a   Lenzi, Andrea ^b   D'Alessandro, Anna M ^a   Carmona, Manuel ^d,e  

^a UNIVERSITY OF L'AQUILA   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c University of Castilla La Mancha   (Spain)

^d UNIVERSITY OF CASTILLA LA MANCHA   (Spain)

^e Albacete Science and Technology Park   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BETA CATENIN; CROCETIN; CROCIN; CROCUS SATIVUS EXTRACT; METALLOPROTEINASE; NERVE CELL ADHESION MOLECULE; UROKINASE; UVOMORULIN; CADHERIN; CAROTENOID; PLANT EXTRACT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER INHIBITION; CONTROLLED STUDY; DOWN REGULATION; ENZYME INHIBITION; EPITHELIAL MESENCHYMAL TRANSITION; GENE REPRESSION; IN VIVO STUDY; MALE; METASTASIS INHIBITION; MOUSE; NONHUMAN; PROSTATE CANCER; PROSTATE CANCER CELL LINE; PROTEIN EXPRESSION; 3T3 CELL LINE; ANIMAL; CELL LINE; CELL TRANSDIFFERENTIATION; CHEMISTRY; CROCUS; DRUG EFFECTS; HUMAN; METABOLISM; NUDE MOUSE; PROSTATIC NEOPLASMS; TUMOR CELL LINE;

ANIMALS; ANTINEOPLASTIC AGENTS; BETA CATENIN; CADHERINS; CAROTENOIDS; CELL LINE; CELL LINE, TUMOR; CELL TRANSDIFFERENTIATION; CROCUS; EPITHELIAL-MESENCHYMAL TRANSITION; HUMANS; MALE; MICE; MICE, NUDE; NIH 3T3 CELLS; PLANT EXTRACTS; PROSTATIC NEOPLASMS;

EID: 84901766158     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2014/135048     Document Type: Article

References (42)

1. Holstein S. A., Hohl R. J., Isoprenoids: remarkable diversity of form and function. Lipids 2004 39 4 293 309 2-s2.0-3242785011 10.1007/s11745-004-1233-3 (Pubitemid 38971743)
2. Abdullaev F. I., González De Mejía E., Antitumor activity of natural substances: lectins and saffron. Archivos Latinoamericanos de Nutricion 1997 47 3 195 202 2-s2.0-0031216857 (Pubitemid 127383589)
3. Carmona M., Zalacain A., Sánchez A. M., Novella J. L., Alonso G. L., Crocetin esters, picrocrocin and its related compounds present in Crocus sativus stigmas and Gardenia jasminoides fruits. Tentative identification of seven new compounds by LC-ESI-MS. Journal of Agricultural and Food Chemistry 2006 54 3 973 979 2-s2.0-33244463729 10.1021/jf052297w (Pubitemid 43274140)
4. Deo B., Growing saffron-the world's most expensive spice. Crop and Food Research 2003 20 1 1 4
5. Melnyk J. P., Wang S., Marcone M. F., Chemical and biological properties of the world's most expensive spice: saffron. Food Research International 2010 43 8 1981 1989 2-s2.0-77957158227 10.1016/j.foodres.2010.07.033
6. Licón C. C., Carmona M., Molina A., Berruga M. I., Chemical, microbiological, textural, color, and sensory characteristics of pressed ewe milk cheeses with saffron (Crocus sativus L.) during ripening. Journal of Dairy Science 2012 95 8 4263 4274
7. Cossignani L., Urbani E., Simonetti M. S., Maurizi A., Chiesi C., Blasi F., Characterisation of secondary metabolites in saffron from central Italy (Cascia, Umbria). Food Chemistry 2014 143 446 451
8. Ulbricht C., Conquer J., Costa D., Hollands W., Iannuzzi C., Isaac R., Jordan J. K., Ledesma N., Ostroff C., Serrano J. M. G., Shaffer M. D., Varghese M., An evidence-based systematic review of saffron (Crocus sativus) by the natural standard research collaboration. Journal of Dietary Supplements 2011 8 1 58 114 2-s2.0-79951990896 10.3109/19390211.2011.547666
9. Abdullaev F. I., Espinosa-Aguirre J. J., Biomedical properties of saffron and its potential use in cancer therapy and chemoprevention trials. Cancer Detection and Prevention 2004 28 6 426 432 2-s2.0-9644268896 10.1016/j.cdp.2004.09.002 (Pubitemid 39568938)
10. Deng Y., Guo Z.-G., Zeng Z.-L., Wang Z., Studies on the pharmacological effects of saffron(Crocus sativus L.)-a review. Zhongguo Zhongyao Zazhi 2002 27 8 565 568 2-s2.0-0642339654
11. Carmona M., Zalacain A., Salinas M. R., Alonso G. L., A new approach to saffron aroma. Critical Reviews in Food Science and Nutrition 2007 47 2 145 159 2-s2.0-33847279360 10.1080/10408390600626511 (Pubitemid 46324806)
12. D'Alessandro A. M., Mancini A., Lizzi A. R., De Simone A., Marroccella C. E., Gravina G. L., Tatone C., Festuccia C., Crocus sativus stigma extract and its major constituent crocin possess significant antiproliferative properties against human prostate cancer. Nutrition and Cancer 2013 65 6 930 942
13. Tavakkol-Afshari J., Brook A., Mousavi S. H., Study of cytotoxic and apoptogenic properties of saffron extract in human cancer cell lines. Food and Chemical Toxicology 2008 46 11 3443 3447 2-s2.0-54449093368 10.1016/j.fct.2008. 08.018
14. Nair S. C., Pannikar B., Panikkar K. R., Antitumour activity of saffron (Crocus sativus). Cancer Letters 1991 57 2 109 114 2-s2.0-0025809643 10.1016/0304-3835(91)90203-T
15. Mousavi S. H., Tavakkol-Afshari J., Brook A., Jafari-Anarkooli I., Role of caspases and Bax protein in saffron-induced apoptosis in MCF-7 cells. Food and Chemical Toxicology 2009 47 8 1909 1913 2-s2.0-68649089717 10.1016/j.fct.2009.05.017
16. Chryssanthi D. G., Dedes P. G., Karamanos N. K., Cordopatis P., Lamari F. N., Crocetin inhibits invasiveness of MDA-MB-231 breast cancer cells via downregulation of matrix metalloproteinases. Planta Medica 2011 77 2 146 151 2-s2.0-78651485607 10.1055/s-0030-1250178
17. Aung H. H., Wang C. Z., Ni M., Fishbein A., Mehendale S. R., Xie J. T., Shoyama C. Y., Yuan C. S., Crocin from Crocus sativus possesses significant anti-proliferation effects on human colorectal cancer cells. Experimental Oncology 2007 29 3 175 180 2-s2.0-36749043785 (Pubitemid 350206742)
18. Bolhassani A., Khavari A., Bathaie S. Z., Saffron and natural carotenoids: biochemical activities and anti-tumor effects. Biochimica et Biophysica Acta 2014 1845 1 20 30
19. Das I., Das S., Saha T., Saffron suppresses oxidative stress in DMBA-induced skin carcinoma: a histopathological study. Acta Histochemica 2010 112 4 317 327 2-s2.0-77953536106 10.1016/j.acthis.2009.02.003
20. Premkumar K., Abraham S. K., Santhiya S. T., Ramesh A., Protective effects of saffron (Crocus sativus Linn.) on genotoxins-induced oxidative stress in Swiss albino mice. Phytotherapy Research 2003 17 6 614 617 2-s2.0-0038125510 10.1002/ptr.1209 (Pubitemid 36781735)
21. Abdullaev F. I., Frenkel G. D., The effect of saffron on intracellular DNA, RNA and protein synthesis in malignant and non-malignant human cells. BioFactors 1992 4 1 43 45 2-s2.0-0027103979 (Pubitemid 23032884)
22. García-López E., González-Gallardo A., Antaramián A., González-Dávalos M. L., Shimada A., Varela-Echavarria A., Mora O., In vitro conversion of β -carotene to retinal in bovine rumen fluid by a recombinant β -carotene- 15, 15′-monooxygenase. International Journal for Vitamin and Nutrition Research 2012 82 2 94 103
23. Molnár J., Kars M. D., Gündüz U., Engi H., Schumacher U., Van Damme E. J., Peumans W. J., Makovitzky J., Gyémánt N., Molnár P., Interaction of tomato lectin with ABC transporter in cancer cells: glycosylation confers functional conformation of P-gp. Acta Histochemica 2009 111 4 329 333 2-s2.0-68949220117
24. Noureini S. K., Wink M., Antiproliferative effects of crocin in HepG2 cells by telomerase inhibition and hTERT down-regulation. Asian Pacific Journal of Cancer Prevention 2012 13 5 2305 2309
25. Kyriakoudi A., Tsimidou M. Z., O'Callaghan Y. C., Galvin K., O'Brien N. M., Changes in total and individual crocetin esters upon in vitro gastrointestinal digestion of saffron aqueous extracts. Journal of Agricultural and Food Chemistry 2013 61 22 5318 5327
26. Sánchez A. M., Carmona M., Ordoudi S. A., Tsimidou M. Z., Alonso G. L., Kinetics of individual crocetin ester degradation in aqueous extracts of saffron (Crocus sativus L.) upon thermal treatment in the dark. Journal of Agricultural and Food Chemistry 2008 56 5 1627 1637 2-s2.0-41949098374 10.1021/jf0730993 (Pubitemid 351506873)
27. Sánchez A. M., Carmona M., Zalacain A., Carot J. M., Jabaloyes J. M., Alonso G. L., Rapid determination of crocetin esters and picrocrocin from saffron spice (Crocus sativus L.) using UV-visible spectrophotometry for quality control. Journal of Agricultural and Food Chemistry 2008 56 9 3167 3175 2-s2.0-44349170194 10.1021/jf703725e (Pubitemid 351746043)
28. Kaighn M. E., Lechner J. F., Shankar Narayan K., Jones L. W., Prostate carcinoma: tissue culture cell lines. National Cancer Institute Monograph 1978 49 17 21 2-s2.0-0018231793 (Pubitemid 9152618)
29. Sramkoski R. M., Pretlow T. G. II, Giaconia J. M., Pretlow T. P., Schwartz S., Sy M.-S., Marengo S. R., Rhim J. S., Zhang D., Jacobberger J. W., A new human prostate carcinoma cell line, 22Rv1. In Vitro Cellular and Developmental Biology-Animal 1999 35 7 403 409 2-s2.0-0032771030 (Pubitemid 29380004)
30. Gravina G. L., Marampon F., Giusti I., Carosa E., Di Sante S., Ricevuto E., Dolo V., Tombolini V., Jannini E. A., Festuccia C., Differential effects of PXD101 (belinostat) on androgen-dependent and androgen-independent prostate cancer models. International Journal of Oncology 2012 40 3 711 720 2-s2.0-84857145666 10.3892/ijo.2011.1270
31. Festuccia C., Muzi P., Gravina G. L., Millimaggi D., Speca S., Dolo V., Ricevuto E., Vicentini C., Bologna M., Tyrosine kinase inhibitor CEP-701 blocks the NTRK1/NGF receptor and limits the invasive capability of prostate cancer cells in vitro. International Journal of Oncology 2007 30 1 193 200 2-s2.0-34250378582
32. Festuccia C., Vincentini C., Di Pasquale A. B., Aceto G., Zazzeroni F., Miano L., Bologna M., Plasminogen activator activities in short-term tissue cultures of benign prostatic hyperplasia and prostatic carcinoma. Oncology Research 1995 7 3-4 131 138 2-s2.0-0029112574
33. Festuccia C., Gravina G. L., D'Alessandro A. M., Muzi P., Milimaggi D., Dolo V., Ricevuto E., Vicentini C., Bologna M., Azacitidine improves antitumor effects of docetaxel and cisplatin in aggressive prostate cancer models. Endocrine-Related Cancer 2009 16 2 401 413 2-s2.0-67650482968 10.1677/ERC-08-0130
34. Bruzzese F., Di Gennaro E., Avallone A., Pepe S., Arra C., Caraglia M., Tagliaferri P., Budillon A., Synergistic antitumor activity of epidermal growth factor receptor tyrosine kinase inhibitor gefitinib and IFN- α in head and neck cancer cells in vitro and in vivo. Clinical Cancer Research 2006 12 2 617 625 2-s2.0-31544451593 10.1158/1078-0432.CCR-05-1671 (Pubitemid 43166157)
35. Kahlert U. D., Nikkhah G., Maciaczyk J., Epithelial-to-mesenchymal(-like) transition as a relevant molecular event in malignant gliomas. Cancer Letters 2013 331 2 131 138
36. Li H., Huang J., Yang B., Xiang T., Yin X., Peng W., Cheng W., Wan J., Luo F., Li H., Ren G., Mangiferin exerts antitumor activity in breast cancer cells by regulating matrix metalloproteinases, epithelial to mesenchymal transition, and β -catenin signaling pathway. Toxicology and Applied Pharmacology 2013 272 1 180 190
37. Ferlay J., Parkin D. M., Steliarova-Foucher E., Estimates of cancer incidence and mortality in Europe in 2008. European Journal of Cancer 2010 46 4 765 781 2-s2.0-76049128595 10.1016/j.ejca.2009.12.014
38. Burgess E. F., Raghavan D., Prostate cancer: what did we learn from the 2012 Annual Scientific Meeting of ASCO? Oncology (Williston Park) 2012 26 12 1216 1221
39. Hadaschik B. A., Sowery R. D., Gleave M. E., Novel targets and approaches in advanced prostate cancer. Current Opinion in Urology 2007 17 3 182 187 2-s2.0-34247145969 10.1097/MOU.0b013e3280dd8a4f (Pubitemid 46597438)
40. Wu C. Y., Tsai Y. P., Wu M. Z., Teng S. C., Wu K. J., Epigenetic reprogramming and post-transcriptional regulation during the epithelial-mesenchymal transition. Trends in Genetics 2012 28 9 454 463
41. Gao Q., Liu W., Cai J., Li M., Gao Y., Lin W., Li Z., EphB2 promotes cervical cancer progression by inducing epithelial-mesenchymal transition. Human Pathology 2014 45 2 372 381
42. Whiteland H., Spencer-Harty S., Thomas D. H., Davies C., Morgan C., Kynaston H., Bose P., Fenn N., Lewis P. D., Bodger O., Jenkins S., Doak S. H., Putative prognostic epithelial-to-mesenchymal transition biomarkers for aggressive prostate cancer. Experimental and Molecular Pathology 2013 95 2 220 226